Dolby Laboratories, Inc.
DLB
$75.34
$0.360.48%
NYSE
| 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.38% | 13.13% | 4.90% | -3.20% | -3.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.38% | 13.13% | 4.90% | -3.20% | -3.02% |
| Cost of Revenue | -7.58% | 27.18% | -4.38% | -14.10% | -5.53% |
| Gross Profit | 2.45% | 11.54% | 6.20% | -1.44% | -2.72% |
| SG&A Expenses | 2.08% | 14.10% | -0.24% | -5.63% | -0.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.18% | 11.77% | -1.41% | -6.70% | -3.22% |
| Operating Income | 5.17% | 17.68% | 66.28% | 25.30% | -2.55% |
| Income Before Tax | -1.23% | 6.46% | 561.29% | 111.15% | 3.81% |
| Income Tax Expenses | 19.08% | 35.69% | 199.20% | 42.94% | 9.98% |
| Earnings from Continuing Operations | -6.10% | 0.72% | 494.13% | 141.73% | 2.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -12.76% | 58.67% | 59.00% | -20,083.33% | -105.35% |
| Net Income | -6.17% | 1.26% | 537.60% | 134.43% | 2.23% |
| EBIT | 5.17% | 17.68% | 66.28% | 25.30% | -2.55% |
| EBITDA | 7.24% | 19.15% | 37.72% | 10.29% | -4.60% |
| EPS Basic | -6.77% | 1.00% | 539.58% | 134.42% | 2.34% |
| Normalized Basic EPS | 3.64% | 5.36% | 50.72% | 29.10% | 1.52% |
| EPS Diluted | -6.93% | 1.45% | 548.06% | 135.29% | 3.06% |
| Normalized Diluted EPS | 3.65% | 5.94% | 51.93% | 29.84% | 1.88% |
| Average Basic Shares Outstanding | 0.64% | 0.25% | -0.32% | 0.03% | -0.11% |
| Average Diluted Shares Outstanding | 0.63% | -0.30% | -1.11% | -0.51% | -0.45% |
| Dividend Per Share | 10.00% | 10.00% | 10.00% | 11.11% | 11.11% |
| Payout Ratio | 0.18% | 0.09% | -0.83% | -0.53% | 0.09% |